Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Repaglinide Tablets”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Large-scale testing (Phase 3)Study completedNCT00399711
What this trial is testing

Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 560
Early research (Phase 1)Study completedNCT00959101
What this trial is testing

Comparison of Repaglinide and Metformin Combination Tablet Versus Repaglinide and Metformin as Separate Tablets in Healthy Volunteers

Who this might be right for
DiabetesHealthy
Novo Nordisk A/S 42
Early research (Phase 1)Study completedNCT01490658
What this trial is testing

Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Fed Healthy Volunteers

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 93
Early research (Phase 1)Study completedNCT07068841
What this trial is testing

Pharmacokinetic Effect of Y-3 on Repaglinide，Warfarin and Omeprazole in Healthy Participants

Who this might be right for
Pharmacokinetic ProfilesY-3 for InjectionDrug-drug Interaction+4 more
Neurodawn Pharmaceutical Co., Ltd. 24
Early research (Phase 1)Study completedNCT01489644
What this trial is testing

Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Healthy Volunteers

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 62